Inogen (INGN) EBT Growth (3y) (2016 - 2026)
Inogen (INGN) EBT Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 17.92% |
| 10 | Inogen | 151.72 Mn | 46.18 Mn | 43.27 Mn | 25.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.76% |
| Mar 31, 2026 | 25.01% |
| Dec 31, 2025 | 29.51% |
| Sep 30, 2025 | 16.77% |
| Jun 30, 2025 | -8.47% |
| Mar 31, 2025 | 23.47% |
| Dec 31, 2024 | 26.33% |
| Sep 30, 2024 | -44.59% |
| Jun 30, 2024 | -35.11% |
| Mar 31, 2024 | -83.46% |
| Dec 31, 2023 | 151.03% |
| Sep 30, 2023 | -187.20% |
| Jun 30, 2023 | -68.40% |
| Mar 31, 2023 | -128.60% |
| Dec 31, 2022 | -137.09% |
| Sep 30, 2022 | -45.46% |
| Jun 30, 2022 | -30.97% |
| Mar 31, 2022 | -62.66% |
| Dec 31, 2021 | -47.10% |
| Sep 30, 2021 | -19.34% |